ArticleClinical case reports2025
Life-Threatening Amlodipine Overdose: A Rare Case of Noncardiogenic Pulmonary Edema and Respiratory Failure Requiring ICU Care.
Article in Clinical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Calcium channel blocker-associated pulmonary toxicity: epidemiology, mechanisms, and clinical management.Frontiers in pharmacology · 2026Review
- Life-Threatening Amlodipine Overdose: A Rare Case of Noncardiogenic Pulmonary Edema and Respiratory Failure Requiring ICU Care.Clinical case reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Amlodipine, a dihydropyridine calcium channel blocker (CCB), is commonly prescribed for hypertension and anginal chest pain. An overdose of this medication can result in life-threatening complications such as vasodilatory shock and pulmonary edema. Noncardiogenic pulmonary edema in this setting is rare and not well understood. We report the case of a 57-year-old female with a complex medical history, including diffuse large B-cell lymphoma (DLBCL) in remission, asthma, and depression, who presented after ingesting approximately 87 tablets (870 mg) of amlodipine in a suicide attempt. The patient developed distributive shock requiring vasopressor support and acute hypoxic respiratory failure due to noncardiogenic pulmonary edema requiring intubation, mechanical ventilation, and intensive care unit (ICU) admission. Her course was complicated by prolonged mechanical ventilation and ventilator-associated pneumonia (VAP), acute kidney injury (AKI), and metabolic derangements. With aggressive supportive therapy-including vasopressors, diuresis, antibiotics, and mechanical ventilation-the patient made a full recovery. This case is notable because NCPE is an uncommon manifestation of amlodipine toxicity [5], and because the patient survived despite multiple comorbidities. Early recognition and multidisciplinary management are critical to survival.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.